Reem Sharaiha is a Gastroenterology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 614 publications with 10,575 citations (h-index 57); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Sponsor: Weill Medical College of Cornell University
- Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise
Sponsor: Weill Medical College of Cornell University
- Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Sponsor: University of Medicine and Pharmacy Craiova
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
8 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.9%Proton pump inhibitor58.2%Omeprazole58%Pantoprazole Sodium35%Esomeprazole Magnesium7%Part D<11 patientsAntidiarrheal microorganisms13.5%Creon73%Zenpep28%Part D<11 patients+ 3 more classes in this area
Anti-infectives
13.1%Fluoroquinolone Antibacterial13.1%Levofloxacin100%Part D≥36 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Honig, MD, PhD
NewYork–Presbyterian Hospital
Michael Niederman, MD
NewYork–Presbyterian Hospital
Shunichi Homma, MD
NewYork–Presbyterian Hospital
David Nanus, MD
NewYork–Presbyterian Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”